Lineage Cell Therapeutics, Inc. (LCTX)
NYSE MKT:LCTX
Holding LCTX?
Track your performance easily

Lineage Therap (LCTX) Financial Statements

1,847 Followers

Lineage Therap Financial Overview

Lineage Therap's market cap is currently ―. The company's EPS TTM is $-0.134; its P/E ratio is -6.87; Lineage Therap is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.41M$ 1.44M$ 2.07M$ 1.25M$ 3.23M
Gross Profit$ 1.36M$ 1.35M$ 1.82M$ 1.08M$ 3.10M
EBIT$ -5.77M$ -6.56M$ -6.36M$ -6.71M$ -5.20M
EBITDA$ -5.63M$ -6.38M$ -6.19M$ -6.53M$ -5.03M
Net Income Common Stockholders$ -5.76M$ -6.54M$ -1.55M$ -7.11M$ -5.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 38.50M$ 43.62M$ 35.49M$ 41.37M$ 45.92M
Total Assets$ 102.80M$ 108.48M$ 101.02M$ 106.15M$ 111.69M
Total Debt$ 2.95M$ 3.25M$ 2.95M$ 3.08M$ 3.40M
Net Debt$ -35.55M$ -40.37M$ -32.54M$ -38.29M$ -42.52M
Total Liabilities$ 35.93M$ 37.49M$ 39.00M$ 39.49M$ 40.43M
Stockholders Equity$ 68.30M$ 72.40M$ 63.42M$ 68.12M$ 72.67M
Cash Flow-
Free Cash Flow$ -5.23M$ -5.82M$ -6.11M$ -5.18M$ -6.52M
Operating Cash Flow$ -5.18M$ -5.78M$ -6.02M$ -5.04M$ -6.27M
Investing Cash Flow$ -8.79M$ -38.00K$ 9.74M$ 2.12M$ 19.16M
Financing Cash Flow$ 105.00K$ 14.02M$ -13.00K$ 807.00K$ 5.63M
Currency in USD

Lineage Therap Earnings and Revenue History

Lineage Therap Debt to Assets

Lineage Therap Cash Flow

Lineage Therap Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis